U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06833203) titled 'Adding Amantadine to Pregabalin on Occurrence of Post-thoracotomy Pain Syndrome' on Feb. 13.
Brief Summary: This study aims to evaluate the additive effect of Amantadine to Pregabaline in the development of post-thoracotomy pain syndrome.
Study Start Date: Dec. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Amantadine
Pregabalin
Post-thoracotomy Pain Syndrome
Intervention:
DRUG: Amantadine+ Pregabalin
Two hours preoperative, patient will receive two capsules, one of them is Amantadine (Amantadine Hydrochloride) 100 mg and the other is Pregabalin (Lyrica) 75 mg and continued on both of them twice daily for 5 days postoperative...